Emcure Pharmaceuticals Limited — Amlodipine Exporter Profile
Indian Pharmaceutical Exporter · #12 for Amlodipine · $7.0M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #12 Indian exporter of Amlodipine with $7.0M in export value and 468 verified shipments. Emcure Pharmaceuticals Limited holds a 0.1% market share in Amlodipine exports across 25 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Amlodipine Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Amlodipine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $4.2M | 115 | 55.4% |
| CANADA | $622.5K | 75 | 8.2% |
| MAURITIUS | $543.9K | 88 | 7.2% |
| NIGERIA | $406.2K | 22 | 5.4% |
| MYANMAR | $250.6K | 60 | 3.3% |
| JAMAICA | $198.9K | 27 | 2.6% |
| TANZANIA | $192.4K | 24 | 2.5% |
| UGANDA | $184.2K | 32 | 2.4% |
| TRINIDAD AND TOBAGO | $120.4K | 8 | 1.6% |
| PANAMA | $120.3K | 66 | 1.6% |
Emcure Pharmaceuticals Limited exports Amlodipine to 29 countries. The largest destination is BRAZIL accounting for 55.4% of Emcure Pharmaceuticals Limited's Amlodipine shipments, followed by CANADA (8.2%) and MAURITIUS (7.2%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amlodipine from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BIOLAB SANUS FARMACEUTICA LTDA | BRAZIL | $3.7M | 105 |
| BIOLAB SANUS FARMACEUTICA LIMITEDA | BRAZIL | $469.2K | 10 |
| FIDSON HEALTHCARE PLC | NIGERIA | $406.2K | 22 |
| MARCAN PHARMACEUTICALS INC. | CANADA | $391.6K | 47 |
| THE MAURITIUS PHARMACY (SEEGOBIN) | MAURITIUS | $298.5K | 31 |
| KHETAN COMPANY LIMITED | MYANMAR | $245.7K | 58 |
| PHILLIPS PHARMACEUTICALS(TANZANIA) | TANZANIA | $180.5K | 18 |
| MEDICAL PRODUCTS LTD. | JAMAICA | $177.9K | 21 |
| MARCAN PHARMACEUTICALS INC | CANADA | $170.2K | 20 |
| HARLEY'S UGANDA LIMITED | UGANDA | $167.9K | 22 |
Emcure Pharmaceuticals Limited supplies Amlodipine to 56 buyers globally. The largest buyer is BIOLAB SANUS FARMACEUTICA LTDA (BRAZIL), followed by BIOLAB SANUS FARMACEUTICA LIMITEDA (BRAZIL) and FIDSON HEALTHCARE PLC (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amlodipine Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $311.2M worth of Amlodipine through 15,000 shipments from 599 suppliers to 159 countries, serving 1,862 buyers globally. Emcure Pharmaceuticals Limited contributes $7.0M to this total, accounting for 0.1% of India's Amlodipine exports. Emcure Pharmaceuticals Limited ships Amlodipine to 29 countries through 56 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Amlodipine Exports?
Emcure Pharmaceuticals Limited's average Amlodipine shipment value is $14.9K per consignment, based on 468 shipments totaling $7.0M. The largest destination is BRAZIL (55.4% of Emcure Pharmaceuticals Limited's Amlodipine exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Amlodipine Exporters?
Emcure Pharmaceuticals Limited ranks #12 among 599 Indian Amlodipine exporters with a 0.1% market share. The top 3 exporters are CIPLA LIMITED ($101.8M), ALKEM LABORATORIES LIMITED ($37.3M), UNICHEM LABORATORIES LIMITED ($34.5M). Emcure Pharmaceuticals Limited processed 468 shipments to 25 destination countries.
What Amlodipine Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS - NOVANLO 2.5 MGTABLET 9X10 ( S (-) AMLODIPINE BESILATETABLETS 2.5MG ) | $450.0K | 9 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - NOVANLO 5 MG TABLET 3X10 ( S (-) AMLODIPINE BESILATE TABLETS 5MG ) | $344.3K | 7 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - NOVANLO 2.5 MG TABLET 3X10 ( S (-)AMLODIPINE BESILATE TABLETS 2.5MG ) | $244.6K | 6 |
| PHARMACEUTICAL PRODUCTS - NOVANLO 5 MG TABLET 9X10 ( S (-) AMLODIPINE BESILATE TABLETS 5MG ) | $212.3K | 6 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): -NOVANLO 5 MG TABLET 9X10 ( S (-) AMLODIPINE BESILATE TABLETS 5MG ) | $200.0K | 4 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - NOVANLO 2.5 MG TABLET 9X10 ( S (-)AMLODIPINE BESILATE TABLETS 2.5MG ) | $192.4K | 5 |
| PHARMACEUTICAL PRODUCTS NOVANLO 2 5 MGTABLET 3X10 S AMLODIPINE BESILATETABLETS 2 5MG | $183.4K | 4 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - COR SELECT 2.5 MG TABLET 6X10 ( S(-) AMLODIPINE BESILATE TABLETS 2.5MG ) | $154.8K | 4 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): -NOVANLO 2.5 MG TABLET 9X10 ( S (-)AMLODIPINE BESILATE TABLETS 2.5MG ) | $127.3K | 5 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - NOVANLO 5 MG TABLET 1X10 ( S (-) AMLODIPINE BESILATE TABLETS 5MG ) | $125.6K | 4 |
Emcure Pharmaceuticals Limited exports 415 distinct Amlodipine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS - NOVANLO 2.5 MGTABLET 9X10 ( S (-) with 9 shipments worth $450.0K.
Regulatory Requirements: Exporting Amlodipine to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Amlodipine to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Amlodipine Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | MICRO LABS LIMITED | $16.0M | 628 | 32 | $25.4K |
| 9 | AJANTA PHARMA LIMITED | $12.4M | 375 | 19 | $33.1K |
| 12 | EMCURE PHARMACEUTICALS LIMITED ★ | $7.0M | 468 | 25 | $14.9K |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $6.8M | 135 | 6 | $50.0K |
| 10 | MEDREICH LIMITED | $5.7M | 113 | 4 | $50.0K |
Emcure Pharmaceuticals Limited ranks #12 among 599 Indian Amlodipine exporters. Average shipment value of $14.9K compared to the market average of $519.5K. The closest competitors by value are MICRO LABS LIMITED and AJANTA PHARMA LIMITED.
Which Indian Ports Ship Amlodipine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 2,082 | 13.9% |
| NHAVA SHEVA SEA (INNSA1) | 1,850 | 12.3% |
| JNPT/ NHAVA SHEVA SEA | 1,599 | 10.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,229 | 8.2% |
| DELHI AIR | 802 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 748 | 5.0% |
| JNPT | 710 | 4.7% |
| Bombay Air | 417 | 2.8% |
What Other Cardiovascular Products Does Emcure Pharmaceuticals Limited Export?
Emcure Pharmaceuticals Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Amlodipine Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Amlodipine, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amlodipine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amlodipine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 712 individual customs records matching Emcure Pharmaceuticals Limited exporting Amlodipine, covering 415 formulations to 29 countries via 56 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 159+ countries, 1,862+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amlodipine Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Amlodipine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Amlodipine Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amlodipine. For current shipment-level data, contact TransData Nexus.